Antiretroviral therapy in children--increased benefit from increased complexity.
作者信息
Cotton M F
机构信息
Department of Paediatrics and Child Health, University of Stellenbosch, Tygerberg, W Cape.
出版信息
S Afr Med J. 2000 Oct;90(10):985-8.
PMID:11081099
Abstract
摘要
相似文献
1
Antiretroviral therapy in children--increased benefit from increased complexity.儿童抗逆转录病毒疗法——复杂性增加带来更多益处。
S Afr Med J. 2000 Oct;90(10):985-8.
2
Providing antiretroviral therapy for HIV infection.为艾滋病毒感染提供抗逆转录病毒疗法。
N Engl J Med. 2001 Mar 15;344(11):844-6. doi: 10.1056/NEJM200103153441112.
3
ARV compliance--the new battle terrain.抗逆转录病毒疗法依从性——新的战场
S Afr Med J. 2004 Aug;94(8):602-3, 605.
4
HIV prevention and treatment in Africa.非洲的艾滋病病毒预防与治疗
AIDS Patient Care STDS. 2000 Aug;14(8):399-400. doi: 10.1089/108729100416597.
5
Antiretroviral therapy in South Africa--can we do it?南非的抗逆转录病毒疗法——我们能做到吗？
S Afr Med J. 2002 Mar;92(3):191-3.
6
[Antiretroviral treatment of HIV infections in poor countries].[贫困国家的艾滋病毒感染抗逆转录病毒治疗]
Tidsskr Nor Laegeforen. 2003 Nov 20;123(22):3255-7.
7
[Drugs for antiretroviral therapy. The costs of HAART].[抗逆转录病毒治疗药物。高效抗逆转录病毒治疗的成本]
MMW Fortschr Med. 2008 Apr 28;150 Spec No 1:21.
8
Cutting the cost of South African antiretroviral therapy using newer, safer drugs.使用更新、更安全的药物降低南非抗逆转录病毒疗法的成本。
S Afr Med J. 2016 Dec 21;107(1):28-30. doi: 10.7196/SAMJ.2016.v107.i1.12058.
9
Preserving future therapeutic options: should we limit the lamivudine use in young HIV-1 infected children initiating first-line HAART?保留未来的治疗选择：我们是否应该限制拉米夫定在初治一线高效抗逆转录病毒治疗的HIV-1感染儿童中的使用？
AIDS. 2013 Jan 14;27(2):151-4. doi: 10.1097/QAD.0b013e32835a99f1.
10
Use of abacavir in 30 HIV-infected children from Durban, South Africa: report from a pilot study.南非德班30名感染艾滋病毒儿童使用阿巴卡韦的情况：一项试点研究报告。
Pediatr Infect Dis J. 2010 Sep;29(9):890. doi: 10.1097/INF.0b013e3181e5a0fe.
引用本文的文献
1
The state of health economic research in South Africa: a systematic review.南非健康经济研究状况：系统评价。
Pharmacoeconomics. 2012 Oct 1;30(10):925-40. doi: 10.2165/11589450-000000000-00000.
Zotero 插件